Lung Cancer

'Nobody deserves cancer': There's a lung cancer stigma, and it's making people sick    Yahoo Lifestyle Learning you have cancer is a difficult diagnosis to bear. But for people with lung cancer, there's an added layer of stress thanks to a pervasive and harmful ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

Study finds specific direct targets for lung cancer treatment    News-Medical.net A team of researchers at the Salk Institute has found two therapeutic targets for the deadly type of lung cancer, non-small-cell lung carcinomas (NSCLCs), which ...

Study finds specific direct targets for lung cancer treatment    News-Medical.net A team of researchers at the Salk Institute has found two therapeutic targets for the deadly type of lung cancer, non-small-cell lung carcinomas (NSCLCs), which ...

Study finds specific direct targets for lung cancer treatment    News-Medical.net A team of researchers at the Salk Institute has found two therapeutic targets for the deadly type of lung cancer, non-small-cell lung carcinomas (NSCLCs), which ...

'Nobody deserves cancer': There's a lung cancer stigma, and it's making people sick    Yahoo Finance Learning you have cancer is a difficult diagnosis to bear. But for people with lung cancer, there's an added layer of stress thanks to a pervasive and harmful ...

This new lung cancer screening tool is designed to catch the disease early on    Yahoo Finance A new test called a low-dose CT scan is designed to catch lung cancer early, when it's more likely to be curable.

'Nobody deserves cancer': There's a lung cancer stigma, and it's making people sick    Yahoo Lifestyle Learning you have cancer is a difficult diagnosis to bear. But for people with lung cancer, there's an added layer of stress thanks to a pervasive and harmful ...

American Lung Association shares lung cancer research and detection advancements for World Lung Cancer Day    WTNH.com In recognition of World Lung Cancer Day on August 1, the American Lung Association in Connecticut is raising awareness and sharing recent medical ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

Study finds specific direct targets for lung cancer treatment    News-Medical.net A team of researchers at the Salk Institute has found two therapeutic targets for the deadly type of lung cancer, non-small-cell lung carcinomas (NSCLCs), which ...

Amgen results beat estimates, lung cancer trial planned    Yahoo Finance Amgen also said its experimental cancer drug AMG510 has shown activity in patients with colorectal and appendiceal cancer, helping to boost the company's ...

Amgen results beat estimates, lung cancer trial planned    Reuters Amgen Inc on Tuesday said its second-quarter revenue fell 3% due to more competition for its older off-patent drugs, but rising sales of newer medicines helped ...

Amgen results beat estimates, lung cancer trial planned    Yahoo Finance Amgen also said its experimental cancer drug AMG510 has shown activity in patients with colorectal and appendiceal cancer, helping to boost the company's ...

Amgen results beat estimates, lung cancer trial planned    Reuters Amgen Inc on Tuesday said its second-quarter revenue fell 3% due to more competition for its older off-patent drugs, but rising sales of newer medicines helped ...

Amgen results beat estimates, lung cancer trial planned    Yahoo Finance Amgen also said its experimental cancer drug AMG510 has shown activity in patients with colorectal and appendiceal cancer, helping to boost the company's ...

Amgen results beat estimates, lung cancer trial planned    Reuters Amgen Inc on Tuesday said its second-quarter revenue fell 3% due to more competition for its older off-patent drugs, but rising sales of newer medicines helped ...

Amgen results beat estimates, lung cancer trial planned    Yahoo Finance Amgen also said its experimental cancer drug AMG510 has shown activity in patients with colorectal and appendiceal cancer, helping to boost the company's ...

Amgen results beat estimates, lung cancer trial planned    Reuters Amgen Inc on Tuesday said its second-quarter revenue fell 3% due to more competition for its older off-patent drugs, but rising sales of newer medicines helped ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

Amgen results beat estimates, lung cancer trial planned    Reuters Amgen Inc on Tuesday said its second-quarter revenue fell 3% due to more competition for its older off-patent drugs, but rising sales of newer medicines helped ...

CT Lung Cancer Screening: How Vivid Images are Reducing Lung Cancer Deaths    UCSF Department of Radiology & Biomedical Imaging A chest computed tomography (CT) scan finds a lung nodule; what is the significance of that? Brett Elicker, MD, chief of Cardiac & Pulmonary Imaging at the UC ...

CT Lung Cancer Screening: How Vivid Images are Reducing Lung Cancer Deaths    UCSF Department of Radiology & Biomedical Imaging A chest computed tomography (CT) scan finds a lung nodule; what is the significance of that? Brett Elicker, MD, chief of Cardiac & Pulmonary Imaging at the UC ...

CT Lung Cancer Screening: How Vivid Images are Reducing Lung Cancer Deaths    UCSF Department of Radiology & Biomedical Imaging A chest computed tomography (CT) scan finds a lung nodule; what is the significance of that? Brett Elicker, MD, chief of Cardiac & Pulmonary Imaging at the UC ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

CT Lung Cancer Screening: How Vivid Images are Reducing Lung Cancer Deaths    UCSF Department of Radiology & Biomedical Imaging A chest computed tomography (CT) scan finds a lung nodule; what is the significance of that? Brett Elicker, MD, chief of Cardiac & Pulmonary Imaging at the UC ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

CT Lung Cancer Screening: How Vivid Images are Reducing Lung Cancer Deaths    UCSF Department of Radiology & Biomedical Imaging A chest computed tomography (CT) scan finds a lung nodule; what is the significance of that? Brett Elicker, MD, chief of Cardiac & Pulmonary Imaging at the UC ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

CT Lung Cancer Screening: How Vivid Images are Reducing Lung Cancer Deaths    UCSF Department of Radiology & Biomedical Imaging A chest computed tomography (CT) scan finds a lung nodule; what is the significance of that? Brett Elicker, MD, chief of Cardiac & Pulmonary Imaging at the UC ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

CT Lung Cancer Screening: How Vivid Images are Reducing Lung Cancer Deaths    UCSF Department of Radiology & Biomedical Imaging A chest computed tomography (CT) scan finds a lung nodule; what is the significance of that? Brett Elicker, MD, chief of Cardiac & Pulmonary Imaging at the UC ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

CT Lung Cancer Screening: How Vivid Images are Reducing Lung Cancer Deaths    UCSF Department of Radiology & Biomedical Imaging A chest computed tomography (CT) scan finds a lung nodule; what is the significance of that? Brett Elicker, MD, chief of Cardiac & Pulmonary Imaging at the UC ...

Man cannot sue DOD following failure to notify him of lung cancer    KRON4 WASHINGTON D.C. – An Army Green Beret says he wants justice after finding out he can't sue his military doctor even after he says that doctor failed to tell him ...

Two therapeutic targets identified for lung cancer    Drug Target Review Salk Institute scientists have discovered a pair of enzymes that drive non-small-cell lung cancer by promoting inflammation.

Study finds specific direct targets for lung cancer treatment    News-Medical.net A team of researchers at the Salk Institute has found two therapeutic targets for the deadly type of lung cancer, non-small-cell lung carcinomas (NSCLCs), which ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

Texas Congressman Ron Wright Battling Lung Cancer    CBS Dallas / Fort Worth WASHINGTON (CBSDFW.COM) – U.S. Rep. Ron Wright (R-Texas) announced on Facebook he has lung cancer, but is not coming home to North Texas anytime ...

Texas Rep. Ron Wright has lung cancer; will seek re-election    Fort Worth Star-Telegram U.S. House District 6 Rep. Ron Wright, R-Arlington, said he was shocked to learn he had lung cancer. The lifelong Texan said cancer won't define him. He said ...

Man cannot sue DOD following failure to notify him of lung cancer    WFLA WASHINGTON D.C. – An Army Green Beret says he wants justice after finding out he can't sue his military doctor even after he says that doctor failed to tell him ...

Man cannot sue DOD following failure to notify him of lung cancer    KRON4 WASHINGTON D.C. – An Army Green Beret says he wants justice after finding out he can't sue his military doctor even after he says that doctor failed to tell him ...

Two Drug Targets Discovered for Deadly Lung Cancer    Technology Networks The vast majority of deadly lung cancer cases (85 percent) are termed non-small-cell lung carcinomas (NSCLCs), which often contain a mutated gene called ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

Therapeutic targets identified for deadly non-small-cell lung carcinomas    Health Europa Two Drug Targets Discovered for Deadly Lung Cancer    Technology Networks Study finds specific direct targets for lung cancer treatment    News-Medical.net Non Small-Cell Lung Cancer Market Size 2019 by Top Key Players and Application with Trend and Growth by 2026 Forecasts    The Market Plan Lung Cancer Therapeutics Market 2015-2021: In-Depth Research on Market Dynamics, Applications & Emerging Growth Factors    Herald Space View full coverage on Google News

Texas Rep. Ron Wright still running for reelection despite lung cancer diagnosis    Dallas News Congressman Ron Wright, R-Arlington, is still running for re-election in 2020, despite battling lung cancer for the last several months, Wright's...

Two Drug Targets Discovered for Deadly Lung Cancer    Technology Networks The vast majority of deadly lung cancer cases (85 percent) are termed non-small-cell lung carcinomas (NSCLCs), which often contain a mutated gene called ...

Texas Congressman Ron Wright Battling Lung Cancer    CBS Dallas / Fort Worth WASHINGTON (CBSDFW.COM) – U.S. Rep. Ron Wright (R-Texas) announced on Facebook he has lung cancer, but is not coming home to North Texas anytime ...

Texas Rep. Ron Wright still running for reelection despite lung cancer diagnosis    Dallas News Congressman Ron Wright, R-Arlington, is still running for re-election in 2020, despite battling lung cancer for the last several months, Wright's...

Texas Congressman Ron Wright Battling Lung Cancer    CBS Dallas / Fort Worth WASHINGTON (CBSDFW.COM) – U.S. Rep. Ron Wright (R-Texas) announced on Facebook he has lung cancer, but is not coming home to North Texas anytime ...

Texas Rep. Ron Wright still running for reelection despite lung cancer diagnosis    Dallas News Congressman Ron Wright, R-Arlington, is still running for re-election in 2020, despite battling lung cancer for the last several months, Wright's...

Texas Congressman Ron Wright Battling Lung Cancer    CBS Dallas / Fort Worth WASHINGTON (CBSDFW.COM) – U.S. Rep. Ron Wright (R-Texas) announced on Facebook he has lung cancer, but is not coming home to North Texas anytime ...

Texas Rep. Ron Wright still running for reelection despite lung cancer diagnosis    Dallas News Congressman Ron Wright, R-Arlington, is still running for re-election in 2020, despite battling lung cancer for the last several months, Wright's...

Texas Congressman Ron Wright Battling Lung Cancer    CBS Dallas / Fort Worth WASHINGTON (CBSDFW.COM) – U.S. Rep. Ron Wright (R-Texas) announced on Facebook he has lung cancer, but is not coming home to North Texas anytime ...

Therapeutic targets identified for deadly non-small-cell lung carcinomas    Health Europa Two Drug Targets Discovered for Deadly Lung Cancer    Technology Networks Study finds specific direct targets for lung cancer treatment    News-Medical.net Non Small-Cell Lung Cancer Market Size 2019 by Top Key Players and Application with Trend and Growth by 2026 Forecasts    The Market Plan Lung Cancer Therapeutics Market 2015-2021: In-Depth Research on Market Dynamics, Applications & Emerging Growth Factors    Herald Space View full coverage on Google News

Texas Rep. Ron Wright still running for reelection despite lung cancer diagnosis    Dallas News Congressman Ron Wright, R-Arlington, is still running for re-election in 2020, despite battling lung cancer for the last several months, Wright's...

Texas Congressman Ron Wright Battling Lung Cancer    CBS Dallas / Fort Worth WASHINGTON (CBSDFW.COM) – U.S. Rep. Ron Wright (R-Texas) announced on Facebook he has lung cancer, but is not coming home to North Texas anytime ...

Non-Small Cell Lung Cancer Therapeutics Market to Expand Impressively at 13.4% CAGR, Increasing Demand for Early Cancer Detection to Enable Growth, says Fortune Business Insights    GlobeNewswire Pune, July 26, 2019 (GLOBE NEWSWIRE) -- The global non-small cell lung cancer therapeutics market is growing impressively due to recent surge in adoption ...

Revolutionary blood test will detect stage 1 lung cancer    ISRAEL21c Israel's Savicell says its test measures the metabolic 'signatures' of immune cells circulating in the blood in response to disease.

Window-of-Opportunity Strategies Continue to Make Headway in Lung Cancer    OncLive The administration of neoadjuvant treatment in patients with lung cancer can not only provide deeper information on an individual tumor, but it could potentially ...

Non-Small Cell Lung Cancer Therapeutics Market to Expand Impressively at 13.4% CAGR, Increasing Demand for Early Cancer Detection to Enable Growth, says Fortune Business Insights    GlobeNewswire Pune, July 26, 2019 (GLOBE NEWSWIRE) -- The global non-small cell lung cancer therapeutics market is growing impressively due to recent surge in adoption ...

Window-of-Opportunity Strategies Continue to Make Headway in Lung Cancer    OncLive The administration of neoadjuvant treatment in patients with lung cancer can not only provide deeper information on an individual tumor, but it could potentially ...

Study finds specific direct targets for lung cancer treatment    News-Medical.net A team of researchers at the Salk Institute has found two therapeutic targets for the deadly type of lung cancer, non-small-cell lung carcinomas (NSCLCs), which ...

Non-Small Cell Lung Cancer Therapeutics Market to Expand Impressively at 13.4% CAGR, Increasing Demand for Early Cancer Detection to Enable Growth, says Fortune Business Insights    GlobeNewswire Pune, July 26, 2019 (GLOBE NEWSWIRE) -- The global non-small cell lung cancer therapeutics market is growing impressively due to recent surge in adoption ...

Window-of-Opportunity Strategies Continue to Make Headway in Lung Cancer    OncLive The administration of neoadjuvant treatment in patients with lung cancer can not only provide deeper information on an individual tumor, but it could potentially ...

Non-Small Cell Lung Cancer Therapeutics Market to Expand Impressively at 13.4% CAGR, Increasing Demand for Early Cancer Detection to Enable Growth, says Fortune Business Insights    GlobeNewswire Pune, July 26, 2019 (GLOBE NEWSWIRE) -- The global non-small cell lung cancer therapeutics market is growing impressively due to recent surge in adoption ...

Window-of-Opportunity Strategies Continue to Make Headway in Lung Cancer    OncLive The administration of neoadjuvant treatment in patients with lung cancer can not only provide deeper information on an individual tumor, but it could potentially ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

About Town: 'Lung Cancer Day' fundraiser, Pancake breakfast benefit    Lompoc Record With Aug. 1 recognized nationally as World Lung Cancer Day, local lung cancer activists have partnered with Yogurt Creations for a fundraiser from 4 to 8 p.m. ...

Immunotherapy Combos, Novel Strategies Aim to Address Unmet Needs in Small Cell Lung Cancer    OncLive With the arrival of immunotherapy to the small cell lung cancer armamentarium, combination approaches with targeted therapies are now in the pipeline to ...

Non-Small Cell Lung Cancer Therapeutics Market to Expand Impressively at 13.4% CAGR, Increasing Demand for Early Cancer Detection to Enable Growth, says Fortune Business Insights    GlobeNewswire Pune, July 26, 2019 (GLOBE NEWSWIRE) -- The global non-small cell lung cancer therapeutics market is growing impressively due to recent surge in adoption ...

Window-of-Opportunity Strategies Continue to Make Headway in Lung Cancer    OncLive The administration of neoadjuvant treatment in patients with lung cancer can not only provide deeper information on an individual tumor, but it could potentially ...

Non-Small Cell Lung Cancer Therapeutics Market to Expand Impressively at 13.4% CAGR, Increasing Demand for Early Cancer Detection to Enable Growth, says Fortune Business Insights    GlobeNewswire Pune, July 26, 2019 (GLOBE NEWSWIRE) -- The global non-small cell lung cancer therapeutics market is growing impressively due to recent surge in adoption ...

Window-of-Opportunity Strategies Continue to Make Headway in Lung Cancer    OncLive The administration of neoadjuvant treatment in patients with lung cancer can not only provide deeper information on an individual tumor, but it could potentially ...

Non-Small Cell Lung Cancer Therapeutics Market to Expand Impressively at 13.4% CAGR, Increasing Demand for Early Cancer Detection to Enable Growth, says Fortune Business Insights    GlobeNewswire Pune, July 26, 2019 (GLOBE NEWSWIRE) -- The global non-small cell lung cancer therapeutics market is growing impressively due to recent surge in adoption ...

Window-of-Opportunity Strategies Continue to Make Headway in Lung Cancer    OncLive The administration of neoadjuvant treatment in patients with lung cancer can not only provide deeper information on an individual tumor, but it could potentially ...

Non-Small Cell Lung Cancer Therapeutics Market to Expand Impressively at 13.4% CAGR, Increasing Demand for Early Cancer Detection to Enable Growth, says Fortune Business Insights    GlobeNewswire Pune, July 26, 2019 (GLOBE NEWSWIRE) -- The global non-small cell lung cancer therapeutics market is growing impressively due to recent surge in adoption ...

Window-of-Opportunity Strategies Continue to Make Headway in Lung Cancer    OncLive The administration of neoadjuvant treatment in patients with lung cancer can not only provide deeper information on an individual tumor, but it could potentially ...

Non-Small Cell Lung Cancer Therapeutics Market to Expand Impressively at 13.4% CAGR, Increasing Demand for Early Cancer Detection to Enable Growth, says Fortune Business Insights    GlobeNewswire Pune, July 26, 2019 (GLOBE NEWSWIRE) -- The global non-small cell lung cancer therapeutics market is growing impressively due to recent surge in adoption ...

Window-of-Opportunity Strategies Continue to Make Headway in Lung Cancer    OncLive The administration of neoadjuvant treatment in patients with lung cancer can not only provide deeper information on an individual tumor, but it could potentially ...

Non-Small Cell Lung Cancer Therapeutics Market to Expand Impressively at 13.4% CAGR, Increasing Demand for Early Cancer Detection to Enable Growth, says Fortune Business Insights    GlobeNewswire Pune, July 26, 2019 (GLOBE NEWSWIRE) -- The global non-small cell lung cancer therapeutics market is growing impressively due to recent surge in adoption ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

GO2 Foundation for Lung Cancer presents lectureship award    Healio GO2 Foundation for Lung Cancer presented Solange Peters, MD, PhD, with the Bonnie J. Addario Lectureship Award. The award recognizes Peters' work in ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

"Hitting the Target" Should Be Focus of Next-Generation Agents in Lung Cancer    OncLive The future generation of agents in lung cancer should be evaluated in improved predictive biomarker-driven trials to identify patients who are most likely to ...

Bristol-Myers Squibb stock falls on lung cancer drug study result    MarketWatch Bristol-Myers Squibb Co. fell in the extended session Wednesday after the drug maker said its lung cancer drug did not achieve one of its goals in a...

Bristol-Myers Squibb stock falls on lung cancer drug study result    MarketWatch Bristol-Myers Squibb Co. fell in the extended session Wednesday after the drug maker said its lung cancer drug did not achieve one of its goals in a...

Bristol-Myers Squibb stock falls on lung cancer drug study result    MarketWatch Bristol-Myers Squibb Co. fell in the extended session Wednesday after the drug maker said its lung cancer drug did not achieve one of its goals in a...

Bristol-Myers Squibb stock falls on lung cancer drug study result    MarketWatch Bristol-Myers Squibb Co. fell in the extended session Wednesday after the drug maker said its lung cancer drug did not achieve one of its goals in a...

Bristol-Myers Squibb stock falls on lung cancer drug study result    MarketWatch Bristol-Myers Squibb Co. fell in the extended session Wednesday after the drug maker said its lung cancer drug did not achieve one of its goals in a...

Salk researchers identify two therapeutic targets for deadly lung cancer    News-Medical.net The vast majority of deadly lung cancer cases (85 percent) are termed non-small-cell lung carcinomas (NSCLCs), which often contain a mutated gene called ...

Bristol-Myers Squibb stock falls on lung cancer drug study result    MarketWatch Bristol-Myers Squibb Co. fell in the extended session Wednesday after the drug maker said its lung cancer drug did not achieve one of its goals in a...

Bristol-Myers Squibb stock falls on lung cancer drug study result    MarketWatch Bristol-Myers Squibb Co. fell in the extended session Wednesday after the drug maker said its lung cancer drug did not achieve one of its goals in a...

Bristol-Myers Squibb stock falls on lung cancer drug study result    MarketWatch Bristol-Myers Squibb Co. fell in the extended session Wednesday after the drug maker said its lung cancer drug did not achieve one of its goals in a...

RJR Argues Florida Smoker Did Not Have Primary Lung Cancer, as Trial Over Her Death Begins    CVN News Attorneys this week argued over whether R.J. Reynolds is responsible for the cancer death of a 42-year-old Florida smoker, as trial opened against the tobacco ...

Bristol-Myers Squibb stock falls on lung cancer drug study result    MarketWatch Bristol-Myers Squibb Co. fell in the extended session Wednesday after the drug maker said its lung cancer drug did not achieve one of its goals in a...

RJR Argues Florida Smoker Did Not Have Primary Lung Cancer, as Trial Over Her Death Begins    CVN News Attorneys this week argued over whether R.J. Reynolds is responsible for the cancer death of a 42-year-old Florida smoker, as trial opened against the tobacco ...

Non-Small Cell Lung Cancer Therapeutics Market to Expand Impressively at 13.4% CAGR, Increasing Demand for Early Cancer Detection to Enable Growth, says Fortune Business Insights    Yahoo Finance Pune, July 26, 2019 -- The global non-small cell lung cancer therapeutics market is growing impressively due to recent surge in adoption of targeted therapy for ...

Roche receives CHMP positive opinion for new Tecentriq-based combination therapy as an initial treatment for most common form of advanced lung cancer    GlobeNewswire Decision based on data showing that the Tecentriq plus chemotherapy combination demonstrated a significant overall survival (OS) and progression-free ...

Update on Frontline Nivolumab/Ipilimumab Combo Demonstrates Positive OS Results in PD-L1+...    Targeted Oncology Nivolumab (Opdivo) in combination with a low dose of ipilimumab (Yervoy) demonstrated an improvement in overall survival (OS) compared with chemotherapy ...

Two therapeutic targets identified for deadly lung cancer    Medical Xpress The vast majority of deadly lung cancer cases (85 percent) are termed non-small-cell lung carcinomas (NSCLCs), which often contain a mutated gene called ...

Dr. Herbst on Immuno-Oncology Combinations in Lung Cancer    OncLive Roy S. Herbst, MD, PhD, chief of medical oncology, professor of medicine, Yale Cancer Center, Smilow Cancer Hospital, discusses combinations with ...

Dr. Herbst on Immuno-Oncology Combinations in Lung Cancer    OncLive Roy S. Herbst, MD, PhD, chief of medical oncology, professor of medicine, Yale Cancer Center, Smilow Cancer Hospital, discusses combinations with ...

Window-of-Opportunity Strategies Continue to Make Headway in Lung Cancer    OncLive The administration of neoadjuvant treatment in patients with lung cancer can not only provide deeper information on an individual tumor, but it could potentially ...

Dr. Herbst on Immuno-Oncology Combinations in Lung Cancer    OncLive Roy S. Herbst, MD, PhD, chief of medical oncology, professor of medicine, Yale Cancer Center, Smilow Cancer Hospital, discusses combinations with ...

Dr. Herbst on Immuno-Oncology Combinations in Lung Cancer    OncLive Roy S. Herbst, MD, PhD, chief of medical oncology, professor of medicine, Yale Cancer Center, Smilow Cancer Hospital, discusses combinations with ...

Dr. Herbst on Immuno-Oncology Combinations in Lung Cancer    OncLive Roy S. Herbst, MD, PhD, chief of medical oncology, professor of medicine, Yale Cancer Center, Smilow Cancer Hospital, discusses combinations with ...